MedTrace Logo

EVEROLD LONG TERM FOLLOW-UP

NCT06504225 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2025-02-06

No results posted yet for this study

Summary

Long Term Follow up of EVEROLD study

Conditions

  • Transplant; Complication, Failure

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Yannick LE MEUR · CHU Brest

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-23
Primary Completion
2025-08-01
Completion
2025-08-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06504225 on ClinicalTrials.gov